| 000 | 01875 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514030628.0 | ||
| 264 | 0 | _c20020816 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a0969-7128 | ||
| 024 | 7 |
_a10.1038/sj.gt.3301671 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNör, J E | |
| 245 | 0 | 0 |
_aAblation of microvessels in vivo upon dimerization of iCaspase-9. _h[electronic resource] |
| 260 |
_bGene therapy _cApr 2002 |
||
| 300 |
_a444-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase 9 |
| 650 | 0 | 4 |
_aCaspases _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDimerization |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xenzymology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Precursors _xgenetics |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aLymphokines _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 | _aMicrocirculation |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 |
_aRetroviridae _xgenetics |
| 650 | 0 | 4 |
_aTacrolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 700 | 1 | _aHu, Y | |
| 700 | 1 | _aSong, W | |
| 700 | 1 | _aSpencer, D M | |
| 700 | 1 | _aNúñez, G | |
| 773 | 0 |
_tGene therapy _gvol. 9 _gno. 7 _gp. 444-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.gt.3301671 _zAvailable from publisher's website |
| 999 |
_c11842025 _d11842025 |
||